CSL511 Fibrinogen concentrate (human) clinical trials

Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery

This study is testing a new medicine called CSL511 for people having major surgery for a condition called pseudomyxoma peritonei. It's for patients who are expected to lose a lot of blood. We want to see if CSL511 works better than a standard treatment to help manage bleeding.